Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010; 60: 277-300; PMID:20610543; http://dx.doi.org/10.3322/caac.20073
   PubMed Web of Science ®Google Scholar
• Henríquez Hernández LA, Lara PC, Pinar B, Bordón E, Rodríguez Gallego C, Bilbao C, Fernández Pérez L, Flores Morales A. Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy. Radiat Oncol 2009; 4: 4-17; http://dx.doi.org/10.1186/1748-717X-4-4
   PubMed Web of Science ®Google Scholar
• Grdina DJ, Murley JS, Kataoka Y. Radioprotectans: current status and new directions. Oncology 2002; 63: 2-10; PMID:12466639; http://dx.doi.org/10.1159/000067146
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. Hall EJ, Giaccia AJ, Eds, Radiobiology for Radiologists. Philadelphia, Lippincott Williams and Wilkins, 2012. ISBN 0781741513, 9780781741514
   Google Scholar
• Medina VA, Croci M, Mohamad NA, Massari N, Garbarino G, Cricco GP, Núñez MA, Martín GA, Crescenti EJ, Bergoc RM, et al. Mechanisms underlying the radioprotective effect of histamine on small intestine. Int J Radiat Biol 2007; 83: 653-63; PMID:17729160; http://dx.doi.org/10.1080/09553000701570238
   PubMed Web of Science ®Google Scholar
• Medina VA, Croci M, Carabajal E, Bergoc RM, Rivera ES. Histamine protects bone marrow against cellular damage induced by ionising radiation. Int J Radiat Biol 2010; 86: 283-90; PMID:20353338; http://dx.doi.org/10.3109/09553000903564067
   PubMed Web of Science ®Google Scholar
• Carabajal E, Massari N, Croci M, Martinel Lamas DJ, Prestifilippo JP, Bergoc RM, Rivera ES, Medina VA. Radioprotective potential of histamine on rat small intestine and uterus. Eur J Histochem 2012; 56: e48; PMID:23361244; http://dx.doi.org/10.4081/ejh.2012.e48
   PubMed Web of Science ®Google Scholar
• Medina VA, Prestifilippo JP, Croci M, Carabajal E, Bergoc RM, Elverdin JC, Rivera ES. Histamine prevents functional and morphological alterations of submandibular glands induced by ionising radiation. Int J Radiat Biol 2011; 87: 284-92; PMID:21142703; http://dx.doi.org/10.3109/09553002.2010.533247
   PubMed Web of Science ®Google Scholar
• Medina VA, Rivera ES. Histamine receptors and cancer pharmacology. British J Pharmacol 2010; 161: 755-67; http://dx.doi.org/10.1111/j.1476-5381.2010.00961.x
   PubMed Web of Science ®Google Scholar
• Rivera ES, Cricco GP, Engel NI, Fitzsimons CP, Martín GA, Bergoc RM. Histamine as an autocrine growth factor: an unusual role for a widespread mediator. Semin Cancer Biol 2000; 10: 15-23; PMID:10888267; http://dx.doi.org/10.1006/scbi.2000.0303
   PubMed Web of Science ®Google Scholar
• Medina V, Cricco G, Nuñez M, Martín G, Mohamad N, Correa-Fiz F, Sanchez-Jimenez F, Bergoc R, Rivera ES. Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol Ther 2006; 5: 1462-71; PMID:17012845; http://dx.doi.org/10.4161/cbt.5.11.3273
   PubMed Web of Science ®Google Scholar
• Davio CA, Cricco GP, Andrade N, Bergoc RM, Rivera ES. H1 and H2 histamine receptors in human mammary carcinomas. Agents Actions 1993; 38: C172-74; http://dx.doi.org/10.1007/BF01996450
   Google Scholar
• Lemos B, Davio C, Gass H, Gonzalez P, Cricco G, Martin G, Bergoc R, Rivera E. Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas. Inflamm Res 1995; 44: S68-9; PMID:8521007; http://dx.doi.org/10.1007/BF01674400
   PubMedGoogle Scholar
• Medina VA, Brenzoni PG, Lamas DJ, Massari N, Mondillo C, Nunez MA, Pignataro O, Rivera ES. Role of histamine H4 receptor in breast cancer cell proliferation. Front Biosci 2011; 18: 1042-60.
   Google Scholar
• Medina V, Croci M, Crescenti E, Mohamad N, Sanchez-Jiménez F, Massari N, Nuñez M, Cricco G, Martin G, Bergoc R, et al. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol Ther 2008; 7: 28-35; http://dx.doi.org/10.4161/cbt.7.1.5123
   PubMed Web of Science ®Google Scholar
• Martinel Lamas DJ, Croci M, Carabajal E, Crescenti EJ, Sambuco L, Massari NA, Bergoc RM, Rivera ES, Medina VA. Therapeutic potential of histamine H4 receptor agonists in triple-negative human breast cancer experimental model. Br J Pharmacol 2013; 170: 188-99; PMID:23425150; http://dx.doi.org/10.1111/bph.12137
   PubMed Web of Science ®Google Scholar
• Medina VA, Massari NA, Cricco GP, Martín GA, Bergoc RM, Rivera ES. Involvement of hydrogen peroxide in histamine-induced modulation of WM35 human malignant melanoma cell proliferation. Free Radic Biol Med 2009; 46: 1510-15; PMID:19285550; http://dx.doi.org/10.1016/j.freeradbiomed.2009.03.003
   PubMed Web of Science ®Google Scholar
• Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007; 99: 365-75; PMID:17341728; http://dx.doi.org/10.1093/jnci/djk064
   PubMed Web of Science ®Google Scholar
• Yang TJ, Ho AY. Radiation therapy in the management of breast cancer. Surg Clin North Am 2013; 93: 455-71; PMID:23464696; http://dx.doi.org/10.1016/j.suc.2013.01.002
   PubMed Web of Science ®Google Scholar
• Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 2008; 76: 947-57; PMID:18657518; http://dx.doi.org/10.1016/j.bcp.2008.06.024
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage. Breast Cancer Res Treat 2000; 62: 223-35; PMID:11072787; http://dx.doi.org/10.1023/A:1006414422919
   PubMed Web of Science ®Google Scholar
• Jasinski P, Terai K, Zwolak P, Dudek AZ. Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C. Eur J Cancer 2000; 44: 1315-22; http://dx.doi.org/10.1016/j.ejca.2008.03.024
   Web of Science ®Google Scholar
• Podtcheko A, Ohtsuru A, Namba H, Saenko V, Starenki D, Palona I, Sedliarou I, Rogounovitch T, Yamashita S. Inhibition of ABL tyrosine kinase potentiates radiation-induced terminal growth arrest in anaplastic thyroid cancer cells. Radiat Res 2006; 165: 35-42; PMID:16392960; http://dx.doi.org/10.1667/RR3466.1
   PubMed Web of Science ®Google Scholar
• Saha GP: Physics and Radiobiology of Nuclear Medicine, New York: Springer-Verlag Inc, 2003.
   Google Scholar
• Kim R, Emi M, Tanabe K. Role of apoptosis in cancer cell survival and therapeutic outcome. Cancer Biol Ther 2006; 52: 1424-29
   Google Scholar
• Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res 2003; 63: 2705-15; PMID:12782571
   PubMed Web of Science ®Google Scholar
• López-Lázaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 2007; 252: 1-8; http://dx.doi.org/10.1016/j.canlet.2006.10.029.
   PubMed Web of Science ®Google Scholar
• L Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001; 293: 829-34; PMID:11486081; http://dx.doi.org/10.1126/science.1061075
   PubMed Web of Science ®Google Scholar
• Chien MH, Ying TH, Yang SF, Yu JK, Hsu CW, Hsieh SC, Hsieh YH. Lipocalin-2 induces apoptosis in human hepatocellular carcinoma cells through activation of mitochondria pathways. Cell Biochem Biophys 2012; 64: 177-86; PMID:22707293; http://dx.doi.org/10.1007/s12013-012-9370-1
   PubMed Web of Science ®Google Scholar
• Yang J, Moses MA. Lipocalin 2: a multifaceted modulator of human cancer. Cell Cycle 2009; 15: 2347-52; http://dx.doi.org/10.4161/cc.8.15.9224
   Web of Science ®Google Scholar
• Roudkenar MH, Kuwahara Y, Baba T, Roushandeh AM, Ebishima S, Abe S, Ohkubo Y, Fukumoto M. Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions. J Radiat Res 2007; 48: 39-44; PMID:17229997; http://dx.doi.org/10.1269/jrr.06057
   PubMed Web of Science ®Google Scholar
• Olive PL, Banáth JP. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 2004; 58: 331-35; PMID:14751500; http://dx.doi.org/10.1016/j.ijrobp.2003.09.028
   PubMed Web of Science ®Google Scholar
• Mah LJ, Orlowski C, Ververis K, Vasireddy RS, El-Osta A, Karagiannis TC. Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks. Genome Integr 2011; 2: 3; PMID:21261999; http://dx.doi.org/10.1186/2041-9414-2-3
   PubMedGoogle Scholar
• Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-63; PMID:9439711; http://dx.doi.org/10.1016/S1383-5742(97)00035-5
   PubMed Web of Science ®Google Scholar
• Farnebo M, Bykov VJ, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun 2010; 396: 85-9; PMID:20494116; http://dx.doi.org/10.1016/j.bbrc.2010.02.152
   PubMed Web of Science ®Google Scholar
• Nagelkerke A, van Kuijk SJ, Sweep FC, Nagtegaal ID, Hoogerbrugge N, Martens JW, Timmermans MA, van Laarhoven HW, Bussink J, Span PN. Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer. Radiother Oncol 2011; 101: 39-45; PMID:21840613; http://dx.doi.org/10.1016/j.radonc.2011.07.009
   PubMed Web of Science ®Google Scholar
• Romero AI, Thorén FB, Aurelius J, Askarieh G, Brune M, Hellstrand K. Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML. Scand J Immunol 2009; 70: 194-205; PMID:19703009; http://dx.doi.org/10.1111/j.1365-3083.2009.02303.x
   PubMed Web of Science ®Google Scholar
• Brouckaert O, Wildiers H, Floris G, Neven P. Update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health 2012; 4: 511-20; PMID:23071421
   PubMedGoogle Scholar
• Amos KD, Adamo B, Anders CK. Triple-negative breast cancer: an update on neoadjuvant clinical trials. Int J Breast Cancer 2012; 2012: 385978; PMID:22461984; http://dx.doi.org/10.1155/2012/385978
   PubMedGoogle Scholar
• Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. Biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-67; PMID:7568133; http://dx.doi.org/10.1073/pnas.92.20.9363
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54; PMID:942051; http://dx.doi.org/10.1016/0003-2697(76)90527-3
   PubMed Web of Science ®Google Scholar
• Policastro L, Molinari B, Larcher F, Blanco P, Podhajcer OL, Costa CS, Rojas P, Durán H. Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide. Mol Carcinogenesis 2004; 39: 103-13; http://dx.doi.org/10.1002/mc.20001
   PubMed Web of Science ®Google Scholar
• Flohé L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984; 105: 114-21; http://dx.doi.org/10.1016/S0076-6879(84)05015-1
   PubMed Web of Science ®Google Scholar
• Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-75; PMID:4623845
   PubMed Web of Science ®Google Scholar